BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.63B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$337M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$172M |
| 4 |
PPG Industries
PPG
|
+$132M |
| 5 |
AGN
Allergan plc
AGN
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian National Railway
CNI
|
+$750M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$525M |
| 3 |
Apple
AAPL
|
+$317M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$275M |
| 5 |
McDonald's
MCD
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.71% |
| 2 | Financials | 8.23% |
| 3 | Healthcare | 5.81% |
| 4 | Consumer Discretionary | 5.23% |
| 5 | Communication Services | 4.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Moog Inc Class A
MOG.A
$13.6B
| $521K | ﹤0.01% |
9,637
+4,753
| +97% | +$306K |
|
1277
Agios Pharmaceuticals
AGIO
$2.04B
| $521K | ﹤0.01% |
7,375
-193
| -3% | -$18.9K |
|
|
SCS
1278
DELISTED
Steelcase
SCS
| $519K | ﹤0.01% |
28,207
-2,332
| -8% | -$41.8K |
|
1279
Direxion Daily Technology Bull 3x ETF
TECL
$6.47B
| $519K | ﹤0.01% |
180,000
| – | – |
|
1280
RLI Corp
RLI
$5.87B
| $519K | ﹤0.01% |
19,378
+7,276
| +60% | +$197K |
|
1281
Marriott Vacations Worldwide
VAC
$4.1B
| $518K | ﹤0.01% |
7,607
-325
| -4% | -$25.5K |
|
1282
PRA Group
PRAA
$762M
| $518K | ﹤0.01% |
9,791
-29,152
| -75% | -$1.69M |
|
1283
First Citizens BancShares
FCNCA
$25.6B
| $518K | ﹤0.01% |
2,290
+808
| +55% | +$198K |
|
1284
Huntsman Corp
HUN
$1.78B
| $517K | ﹤0.01% |
53,391
-121,471
| -69% | -$2.09M |
|
1285
Range Resources
RRC
$9.39B
| $517K | ﹤0.01% |
16,089
-33,664
| -68% | -$1.31M |
|
1286
Fair Isaac
FICO
$24B
| $516K | ﹤0.01% |
6,111
+3,758
| +160% | +$331K |
|
|
PDM
1287
Piedmont Realty Trust
PDM
$1.19B
| $516K | ﹤0.01% |
28,847
-24,642
| -46% | -$440K |
|
1288
Dillards
DDS
$9.93B
| $515K | ﹤0.01% |
5,898
-26,888
| -82% | -$2.6M |
|
|
SHLD
1289
DELISTED
Sears Holding Corporation
SHLD
| $515K | ﹤0.01% |
22,799
-5,369
| -19% | -$130K |
|
1290
Avient
AVNT
$4.16B
| $515K | ﹤0.01% |
17,554
+10,798
| +160% | +$365K |
|
1291
Cimpress
CMPR
$2.4B
| $515K | ﹤0.01% |
6,765
+4,036
| +148% | +$300K |
|
|
MDCO
1292
DELISTED
Medicines Co
MDCO
| $515K | ﹤0.01% |
13,560
+8,050
| +146% | +$283K |
|
|
CLVS
1293
DELISTED
Clovis Oncology, Inc.
CLVS
| $512K | ﹤0.01% |
5,572
+3,503
| +169% | +$303K |
|
1294
G-III Apparel Group
GIII
$1.41B
| $510K | ﹤0.01% |
8,269
+4,782
| +137% | +$328K |
|
1295
Dana Inc
DAN
$3.26B
| $510K | ﹤0.01% |
32,107
+9,890
| +45% | +$179K |
|
1296
Mettler-Toledo International
MTD
$28.8B
| $510K | ﹤0.01% |
1,790
+1,762
| +6,293% | +$557K |
|
1297
Wolverine World Wide
WWW
$1.63B
| $508K | ﹤0.01% |
23,471
-18,765
| -44% | -$511K |
|
|
DBD
1298
DELISTED
Diebold Nixdorf Incorporated
DBD
| $508K | ﹤0.01% |
17,057
-11,884
| -41% | -$386K |
|
1299
Pebblebrook Hotel Trust
PEB
$2.05B
| $504K | ﹤0.01% |
14,206
+3,315
| +30% | +$133K |
|
1300
Travere Therapeutics
TVTX
$5.79B
| $502K | ﹤0.01% |
24,782
+11,873
| +92% | +$352K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2015 Portfolio in Review
As of Q3 2015, BNP Paribas Financial Markets held 3,791 positions worth $39.9B, up 11% from $35.8B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
BNP Paribas Financial Markets deployed $7.43B of net new capital in Q3 2015, opening 248 new positions and adding to 2,429 existing holdings. Its largest new stake was Allergan plc: 397,434 shares worth $108M.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 10% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $525M trimmed.
- BNP Paribas Financial Markets's largest Q3 2015 buy was Allergan plc: 397,434 shares worth $108M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q3 2015, an estimated $5.63B increase.
- BNP Paribas Financial Markets's biggest Q3 2015 reduction was iShares Russell 2000 ETF, cutting an estimated $525M.
- BNP Paribas Financial Markets fully exited Canadian National Railway in Q3 2015, selling an estimated $750M.
- BNP Paribas Financial Markets's ten largest holdings make up 45% of its $39.9B portfolio in Q3 2015.
- BNP Paribas Financial Markets opened 248 new positions and closed 172 in Q3 2015.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $39.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2015, filed 13 Nov 2015.